The increasing prevalence of Farmapram, a brand name containing the active ingredient alprazolam, has raised significant attention regarding its availability and the potential risks. While prescribed for the management of anxiety disorders and panic attacks, concerns are mounting about its widespread procurement, particularly through unverified ven